These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8261613)

  • 1. Neonatal exposure to D,L-2-amino-3-phosphonopropionate (D,L-AP3) produces lesions in the eye and optic nerve of adult rats.
    Fix AS; Schoepp DD; Olney JW; Vestre WA; Griffey KI; Johnson JA; Tizzano JP
    Brain Res Dev Brain Res; 1993 Oct; 75(2):223-33. PubMed ID: 8261613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive retinal toxicity in neonatal rats treated with D,L-2-amino-3-phosphonopropionate (D,L-AP3).
    Fix AS; Horn JW; Hall RL; Johnson JA; Tizzano JP
    Vet Pathol; 1995 Sep; 32(5):521-31. PubMed ID: 8578643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the second messenger functions of the glutamate metabotropic receptor is associated with degenerative changes in the retina and brain of immature rodents.
    Price MT; Romano C; Fix AS; Tizzano JP; Olney JW
    Neuropharmacology; 1995 Aug; 34(8):1069-79. PubMed ID: 8532156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulatory effects of the putative metabotropic glutamate receptor antagonist L-AP3 on phosphoinositide turnover in neonatal rat cerebral cortex.
    Mistry R; Prabhu G; Godwin M; Challiss RA
    Br J Pharmacol; 1996 Mar; 117(6):1309-17. PubMed ID: 8882630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabotropic glutamate receptor antagonist L-2-amino-3-phosphonopropionic acid inhibits phosphoserine phosphatase.
    Hawkinson JE; Acosta-Burruel M; Wood PL
    Eur J Pharmacol; 1996 Jun; 307(2):219-25. PubMed ID: 8832224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxic effect of high dose of L-(+)-2-amino-3-phosphonopropionic acid in rats after intracaudatal injection.
    Yuan F; Wang TY; Xu LX; Sun YL; Luo L; Qu BQ
    Acta Pharmacol Sin; 2001 Jun; 22(6):556-60. PubMed ID: 11747764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two components in neurotoxicity by L-2-amino-3-phosphonopropionate in cultured cerebellar neurons.
    Novelli A; Torreblanca A; Fernández-Sánchez MT
    Eur J Pharmacol; 1994 Aug; 270(4):361-4. PubMed ID: 7805786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swelling of Müller cells induced by AP3 and glutamate transport substrates in rat retina.
    Izumi Y; Kirby-Sharkey CO; Benz AM; Mennerick S; Labruyere J; Price MT; Olney JW; Zorumski CF
    Glia; 1996 Aug; 17(4):285-93. PubMed ID: 8856325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-activation of metabotropic glutamate and N-methyl-D-aspartate receptors is involved in mechanisms of long-term potentiation maintenance in rat hippocampal CA1 neurons.
    Behnisch T; Reymann KG
    Neuroscience; 1993 May; 54(1):37-47. PubMed ID: 8515845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-2-amino-3-phosphonopropionate blocks late synaptic long-term potentiation.
    Behnisch T; Fjodorow K; Reymann KG
    Neuroreport; 1991 Jul; 2(7):386-8. PubMed ID: 1655108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha chymotrypsin on the canine eye.
    Barrie KP; Gelatt KN; Gum GG; Samuelson DA
    Am J Vet Res; 1982 Feb; 43(2):207-16. PubMed ID: 6979957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of L-glutamate and trans-(+-)-1-amino-1,3-cyclopentanedicarboxylate on phosphoinositide hydrolysis can be pharmacologically differentiated.
    Littman L; Robinson MB
    J Neurochem; 1994 Oct; 63(4):1291-302. PubMed ID: 7931281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein activation by metabotropic glutamate receptors reduces spike frequency adaptation in neocortical neurons.
    Burke JP; Hablitz JJ
    Neuroscience; 1996 Nov; 75(1):123-31. PubMed ID: 8923528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models.
    Taniguchi T; Shimazawa M; Hara H
    Brain Res; 2004 Jul; 1013(2):241-8. PubMed ID: 15193534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niemann-Pick disease-like inclusions caused by a hypocholesteremic agent.
    Sakuragawa M
    Invest Ophthalmol; 1976 Dec; 15(12):1022-7. PubMed ID: 62729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective synergism of 2-amino-3-phosphonoproprionate (D,L-AP3) and MK-801 against ibotenate induced brain injury.
    McDonald JW; Johnston MV
    Neurosci Lett; 1992 Oct; 145(2):213-6. PubMed ID: 1361225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Amino-3-phosphonopropionate fails to block postsynaptic effects of metabotropic glutamate receptors in rat hippocampal neurones.
    Hu GY; Storm JF
    Acta Physiol Scand; 1992 Jun; 145(2):187-91. PubMed ID: 1322019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of metabotropic glutamate receptors for the generation of inflammation-evoked hyperexcitability in rat spinal cord neurons.
    Neugebauer V; Lücke T; Schaible HG
    Eur J Neurosci; 1994 Jul; 6(7):1179-86. PubMed ID: 7524965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental changes in the effects of metabotropic glutamate receptor antagonists on CA1 long-term potentiation in rat hippocampal slices.
    Izumi Y; Zorumski CF
    Neurosci Lett; 1994 Jul; 176(1):89-92. PubMed ID: 7970244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cataracts and optic nerve hypoplasia in turkey poults.
    Barr BC; Murphy CJ; Ghazikhanian GY; Bellhorn RW
    Avian Dis; 1988; 32(3):469-77. PubMed ID: 3196262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.